Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($) |
Preferred Stock Series I [Member] |
Preferred Stock Series H [Member] |
Preferred Stock Series G [Member] |
Preferred Stock Series F [Member] |
Common Stock [Member] |
Common Stock To Be Issued [Member] |
Preferred Stock To Be Issued [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
AOCI Attributable to Parent [Member] |
Total Dalrada Financial Corps Stockholders Deficit [Member] |
Noncontrolling Interest [Member] |
Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance, value at Jun. 30, 2022 | $ 0 | $ 0 | $ 100.00 | $ 50 | $ 360,855 | $ 1,066,925 | $ 0 | $ 104,627,032 | $ (121,436,490) | $ (50,673) | $ (15,432,201) | $ 479,019 | $ (14,953,182) |
Beginning balance, shares at Jun. 30, 2022 | 0 | 0 | 10,002 | 5,000 | 72,174,620 | ||||||||
Conversion of related party notes into preferred stock | $ 351 | $ 150 | 33,859,043 | 33,859,544 | 33,859,544 | ||||||||
Beginning balance, shares | 35,108 | 15,022 | |||||||||||
Warrants issued pursuant to acquisitions | 5,751 | 5,751 | 5,751 | ||||||||||
Common stock issued for conversion of convertibles notes, accrued interest and premium | 54,873 | 1,392,615 | 1,447,488 | 1,447,488 | |||||||||
Stock-based compensation | $ 2,500 | (175,000) | 4,195,156 | 4,022,656 | 4,022,656 | ||||||||
Beginning balance, shares | 500,000 | ||||||||||||
Beginning balance, shares | 10,974,520 | ||||||||||||
Net loss | (20,292,519) | (20,292,519) | (335,202) | (20,627,721) | |||||||||
Common stock issued pursuant to acquisitions | 15,250 | (699,000) | 998,225 | 314,475 | 314,475 | ||||||||
Foreign currency translation | (175) | (175) | (175) | ||||||||||
Beginning balance, shares | 3,049,999 | ||||||||||||
Common stock issued pursuant to consultant agreement | $ 10,000 | 174,000 | 184,000 | 184,000 | |||||||||
Beginning balance, shares | 2,000,000 | ||||||||||||
Beginning balance, shares at Jun. 30, 2023 | 35,108 | 15,022 | 10,002 | 5,000 | 88,699,139 | ||||||||
Ending balance, value at Jun. 30, 2023 | $ 351 | $ 150 | $ 100 | $ 50 | $ 443,478 | 192,925 | 0 | 145,251,822 | (141,729,009) | (50,848) | 4,109,019 | 143,817 | 4,252,836 |
Stock-based compensation | 5,087,315 | 5,087,315 | 5,087,315 | ||||||||||
Net loss | (28,948,057) | (28,948,057) | (237,841) | (29,185,898) | |||||||||
Foreign currency translation | 49,939 | 49,939 | 49,939 | ||||||||||
Common stock issued pursuant to acquisitions | $ 8,048 | (192,925) | 4,596,334 | 386,093 | 4,797,550 | 4,797,550 | |||||||
Beginning balance, shares | 1,609,639 | ||||||||||||
Common stock issued pursuant to debt agreement | $ 5,000 | 228,000 | 233,000 | 233,000 | |||||||||
Beginning balance, shares | 1,000,000 | ||||||||||||
Conversion of related party notes into preferred stock | 17,243,442 | 17,243,442 | 17,243,442 | ||||||||||
Warrants issued pursuant to acquisitions | 22,722 | 22,722 | 22,722 | ||||||||||
Common stock issued pursuant to consulting agreement | $ 6,000 | 235,200 | 241,200 | 241,200 | |||||||||
Beginning balance, shares | 1,200,000 | ||||||||||||
Common stock issued pursuant to private placement | $ 23,351 | 580,650 | 604,001 | 604,001 | |||||||||
Beginning balance, shares | 4,666,665 | ||||||||||||
Beginning balance, shares at Jun. 30, 2024 | 35,108 | 15,022 | 10,002 | 5,000 | 97,175,443 | ||||||||
Ending balance, value at Jun. 30, 2024 | $ 351 | $ 150 | $ 100 | $ 50 | $ 485,877 | $ 0 | $ 21,839,776 | $ 151,791,802 | $ (170,667,066) | $ (909) | $ 3,440,131 | $ (94,024) | $ 3,346,107 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. No definition available.
|
X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|